Literature DB >> 177368

Fate of interferon-treated cells.

R M Friedman, J R Costa.   

Abstract

Interferon-treated cultures of Ly cells survived initial infection with high multiplicities of vesicular stomatitis (VSV) or herpes simplex virus (HSV). In the case of HSV, infectious virus and intracellular viral antigen were rapidly eliminated from the interferon-treated cultures, and the cells grew out to form apparently normal monolayers that could be cultured indefinitely. In the VSV-infected Ly cultures, virus titers remained at low levels in interferon-treated cells but after about 14 days rapidly rose and the culture was destroyed. If interferon was added to the medium on days 4 and 6 after infection, virus titers rapidly declined but again recovered and the cells were destroyed. If, however, interferon treatment was resumed 9 days after initial infection, detectable infectious VSV was eliminated from the medium. Several methods, including cocultivation and molecular hybridization, failed to demonstrate persistence of a significant portion of the VSV genome in these cultures.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 177368      PMCID: PMC420638          DOI: 10.1128/iai.13.2.487-493.1976

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  12 in total

1.  PURIFICATION OF VESICULAR STOMATITIS VIRUS AND THE ANALYSIS OF P32-LABELED VIRAL COMPONENTS.

Authors:  L PREVEC; G F WHITMORE
Journal:  Virology       Date:  1963-07       Impact factor: 3.616

2.  Persistent infection with herpes simplex virus in vitro. 1. Establishment and characteristics of persistent herpes simplex virus infection in Earle's L cells.

Authors:  S Nii
Journal:  Biken J       Date:  1969-06

3.  Infectious DNA of tick-borne encephalitis virus.

Authors:  V M Zhdanov; N N Bogomolova; V I Gavrilov; O G Andzhaparidze; P G Deryabin; A N Astakhova
Journal:  Arch Gesamte Virusforsch       Date:  1974

4.  Integration of measles virus nucleic acid into the cell genome.

Authors:  V M Zhdanov; M I Parfanovich
Journal:  Arch Gesamte Virusforsch       Date:  1974

5.  The effect of interferon on SV-40 T antigen production in SV-40-transformed cells.

Authors:  M N Oxman; S Baron; P H Black; K K Takemoto; K Habel; W P Rowe
Journal:  Virology       Date:  1967-05       Impact factor: 3.616

6.  The role of interferon in the inhibition of SV40 transformation of mouse cell line 3T3.

Authors:  G J Todaro; S Baron
Journal:  Proc Natl Acad Sci U S A       Date:  1965-09       Impact factor: 11.205

7.  Recovery of infectious proviral DNA from mammalian cells infected with respiratory syncytial virus.

Authors:  R W Simpson; M Iinuma
Journal:  Proc Natl Acad Sci U S A       Date:  1975-08       Impact factor: 11.205

8.  Herpesvirus hominis: isolation from human trigeminal ganglion.

Authors:  F O Bastian; A S Rabson; C L Yee; T S Tralka
Journal:  Science       Date:  1972-10-20       Impact factor: 47.728

9.  The role of interferon in vaccinia virus infection of mouse embryo tissue culture.

Authors:  L A GLASGOW; K HABEL
Journal:  J Exp Med       Date:  1962-03-01       Impact factor: 14.307

10.  Mengovirus-induced cytopathic effect in L-cells: protective effect of interferon.

Authors:  A T Haase; H Levy; S Baron; J A Kasel
Journal:  J Virol       Date:  1969-10       Impact factor: 5.103

View more
  4 in total

Review 1.  Mechanisms of persistent infections by cytopathic viruses in tissue culture. Brief review.

Authors:  R M Friedman; J M Ramseur
Journal:  Arch Virol       Date:  1979       Impact factor: 2.574

Review 2.  Antiviral activity of interferons.

Authors:  R M Friedman
Journal:  Bacteriol Rev       Date:  1977-09

3.  Human cytomegalovirus persists in cells treated with interferon. Brief report.

Authors:  J E Rodriguez; T R Loepfe; M F Stinski
Journal:  Arch Virol       Date:  1983       Impact factor: 2.574

4.  Persistent viral infections as models for research in virus chemotherapy.

Authors:  G Streissle
Journal:  Adv Virus Res       Date:  1981       Impact factor: 9.937

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.